Page last updated: 2024-08-25

cromakalim and 1-(3-sulfonatopropyl)-4-(beta)(2-(di-n-butylamino)-6-naphthylvinyl)pyridinium betaine

cromakalim has been researched along with 1-(3-sulfonatopropyl)-4-(beta)(2-(di-n-butylamino)-6-naphthylvinyl)pyridinium betaine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, PS; Garfinkel, A; Karagueuzian, HS; Kil, JR; Kim, YH; Lee, MH; Qu, Z; Voroshilovsky, O; Weiss, JN	1

Other Studies

1 other study(ies) available for cromakalim and 1-(3-sulfonatopropyl)-4-(beta)(2-(di-n-butylamino)-6-naphthylvinyl)pyridinium betaine

Article	Year
Preventing ventricular fibrillation by flattening cardiac restitution. Proceedings of the National Academy of Sciences of the United States of America, 2000, May-23, Volume: 97, Issue:11 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiac Pacing, Artificial; Computer Simulation; Cromakalim; Diastole; Drug Design; Drug Evaluation, Preclinical; Fluorescent Dyes; Heart Conduction System; Models, Biological; Pyridinium Compounds; Swine; Ventricular Fibrillation	2000

Article

Year

Preventing ventricular fibrillation by flattening cardiac restitution.

Proceedings of the National Academy of Sciences of the United States of America, 2000, May-23, Volume: 97, Issue:11

Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiac Pacing, Artificial; Computer Simulation; Cromakalim; Diastole; Drug Design; Drug Evaluation, Preclinical; Fluorescent Dyes; Heart Conduction System; Models, Biological; Pyridinium Compounds; Swine; Ventricular Fibrillation

2000